Caregiver Burden of Autosomal Dominant Polycystic Kidney Disease: A Qualitative StudyPlain-Language Summary

Caregiver Burden of Autosomal Dominant Polycystic Kidney Disease: A Qualitative StudyPlain-Language Summary

Rationale & Objective: There is limited published research on how autosomal dominant polycystic kidney disease (ADPKD) impacts caregivers. This study explored how caregivers of individuals with ADPKD perceive the burdens placed on them by the disease. Study Design: Qualitative study consisti...

Full description

Bibliographic Details
Main Authors:	Dorothee Oberdhan, Andrew C. Palsgrove, Jason C. Cole, Tess Harris
Format:	Article
Language:	English
Published:	Elsevier 2023-02-01
Series:	Kidney Medicine
Subjects:	Autosomal dominant polycystic kidney disease (ADPKD) burden caregiver quality of life
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590059522002205

Similar Items

Polycystic Kidney Disease–Related Disease Burden in Adolescents With Autosomal Dominant Polycystic Kidney Disease: An International Qualitative StudyPlain-Language Summary
by: Dorothee Oberdhan, et al.
Published: (2022-03-01)

Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease
by: Dorothee Oberdhan, et al.
Published: (2024-01-01)

Disconnect in Assessments of Autosomal Dominant Polycystic Kidney Disease Burden Between Patients and Physicians: A Survey Study
by: Sanon Aigbogun M, et al.
Published: (2021-04-01)

Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations
by: Sans-Atxer L, et al.
Published: (2018-01-01)

Effects of tolvaptan discontinuation in patients with autosomal dominant polycystic kidney disease: a post hoc pooled analysis
by: Michael Lioudis, et al.
Published: (2023-06-01)

The Relationship Between Dietary Intakes and Total Kidney Volume in Patients with Autosomal Dominant Polycystic Kidney Disease Dietary Intake and Polycystic Kidney Volume
by: Yonca Sevim, et al.
Published: (2022-09-01)

Clinical findings, underlying pathogenetic processes and treatment of vascular dysfunction in autosomal dominant polycystic kidney disease
by: Jinjun Zhu, et al.
Published: (2023-12-01)

The societal economic burden of autosomal dominant polycystic kidney disease in the United States
by: Martin Cloutier, et al.
Published: (2020-02-01)

The Effect of Smoking on Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease Patients with Preserved Renal Function
by: Cuma Bulent Gul, et al.
Published: (2021-01-01)

Autosomal Dominant Polycystic Kidney Disease: Review and Management Update
by: Víctor Martínez
Published: (2014-07-01)

Applications of Herbal Medicine to Treat Autosomal Dominant Polycystic Kidney Disease
by: Guangying Shao, et al.
Published: (2021-04-01)

Metabolism-based approaches for autosomal dominant polycystic kidney disease
by: Ivona Bakaj, et al.
Published: (2023-02-01)

Elevated Asymmetric Dimethylarginine is Associated With Oxidant Stress Aggravation in Patients With Early Stage Autosomal Dominant Polycystic Kidney Disease
by: Vassilios Raptis, et al.
Published: (2014-02-01)

Mutation Analysis of Autosomal-Dominant Polycystic Kidney Disease Patients
by: Yasuo Suzuki, et al.
Published: (2023-02-01)

A novel heterozygous PKD1 variant causing alternative splicing in a Chinese family with autosomal dominant polycystic kidney disease
by: Qianying Zhao, et al.
Published: (2023-08-01)

Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical Trial
by: Maria V. Irazabal, et al.
Published: (2016-11-01)

AUTOSOMAL – DOMINANT POLYCYSTIC KIDNEY DISEASE – A GLEAM OF HOPE?
by: V.V. Doretskyi, et al.
Published: (2014-01-01)

Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers
by: Iva Sorić Hosman, et al.
Published: (2023-11-01)

Real-Time High Resolution Melting Analysis-PCR for Assessment of Gene Mutations in Human Autosomal Dominant Polycystic Kidney Disease
by: Mohd Jas, Rusni
Published: (2011)

Clinical and genetic study of a Chinese family affected by both amyotrophic lateral sclerosis and autosomal dominant polycystic kidney disease
by: Shirong Li, et al.
Published: (2022-10-01)

The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease
by: Ryo Matsuura, et al.
Published: (2017-01-01)

A case of pulmonary embolism caused by compression of the vena cava by intra‐abdominal masses in autosomal polycystic kidney disease
by: Christopher Holzmann‐Littig, et al.
Published: (2020-07-01)

Pain in Autosomal Dominant Polycystic Kidney Disease
by: Mariusz Niemczyk
Published: (2014-07-01)

Modified Supine Hand Assisted Laparoscopic (HAL) bilateral nephrectomy for Autosomal Dominant Polycystic Kidney Disease (ADPKD): A Step-by-Step technique
by: Ee Jean Lim, et al.
Published: (2021-09-01)

Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling
by: Xia Zhou, et al.
Published: (2022-09-01)

Tolvaptan: a possible preemptive treatment option in children with autosomal dominant polycystic kidney disease?
by: Hee Sun Beak, et al.
Published: (2023-12-01)

Healthcare resource consumption and cost of care among patients with polycystic kidney disease in Italy
by: Degli Esposti L, et al.
Published: (2017-04-01)

Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment
by: Jana Reiterová, et al.
Published: (2022-03-01)

Femoral Neuropathy Secondary to Autosomal Dominant Polycystic Kidney Disease: A Case Report
by: Jeehyun Yoo, et al.
Published: (2018-06-01)

Management of nephrolithiasis in autosomal dominant polycystic kidney disease - A single center experience
by: Ramen Baishya, et al.
Published: (2012-01-01)

Early Markers of Cardiovascular Risk in Autosomal Dominant Polycystic Kidney Disease
by: Silvia Lai, et al.
Published: (2017-12-01)

Autosomal Dominant Polycystic Kidney Disease and Pericardial Effusion
by: Guillermo Alberto Perez Fernandez, et al.
Published: (2018-09-01)

Renal Transplantation in Autosomal Dominant Polycystic Kidney Disease
by: Andrzej Kulesza, et al.
Published: (2015-07-01)

Tolvaptan in Pediatric Autosomal Dominant Polycystic Kidney Disease: From Here to Where?
by: Fei Liu, et al.
Published: (2021-07-01)

Zebrafish Model as a Screen to Prevent Cyst Inflation in Autosomal Dominant Polycystic Kidney Disease
by: Inês Oliveira, et al.
Published: (2021-08-01)

Chronic brucellosis with hepatic brucelloma and AA amyloidosis in a patient with autosomal dominant polycystic kidney disease
by: Arpitha Kollabathula, et al.
Published: (2020-01-01)

LAPAROSCOPIC NEPHRECTOMY IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
by: O. N. Reznik, et al.
Published: (2016-11-01)

Executive Summary: Clinical Practice Guideline for Autosomal Dominant Polycystic Kidney Disease in China
by: Chang-Lin Mei, et al.
Published: (2020-03-01)

Results of kidney transplantation in patients with end-stage renal failure caused by autosomal dominant polycystic kidney disease
by: V. S. Daineko, et al.
Published: (2019-07-01)

Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease
by: Yaerim Kim, et al.
Published: (2023-05-01)